首页 | 本学科首页   官方微博 | 高级检索  
     


ATM,THMS, and RRM1 protein expression in nasopharyngeal carcinomas treated with curative intent
Authors:Jenny Jaeeun Ko MD  FRCPC  Alexander C. Klimowicz PhD  Amanda Jagdis MD  Tien Phan MD  FRCPC  Janessa Laskin MD  FRCPC  Harold Y. Lau MD  FRCPC  Jodi E. Siever MSc  Stephanie K. Petrillo MSc  Thomas A. Thomson MD  FRCPC  M. Sarah Rose PhD  Gwyn Bebb MBMCh  PhD   FRCPC  Anthony M. Magliocco MD  FRCPC   FCAP  Desirée Hao MD  FRCPC
Affiliation:1. Department of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada;2. Functional Tissue Imaging Unit, Translational Research Laboratory, University of Calgary, Calgary, Alberta, Canada;3. Department of Allergy and Immunology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada;4. Department of Radiation Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada;5. Department of Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada;6. Department of Biostatistics, Public Health Innovation & Decision Support Population and Public Health, Alberta Health Services, Alberta, Canada;7. Department of Pathology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada;8. Department of Biostatistics, Research Facilitation, Alberta Health Services, Alberta, Canada;9. Department of Anatomic Pathology, Esoteric Laboratory Services, H. Lee Moffitt Cancer Center, Tampa, Florida
Abstract:
Keywords:ataxia‐telangiectasia mutated (ATM)  thymidylate synthetase (THMS)  ribonucleotide reductase subunit M1 (RRM1)  nasopharyngeal carcinoma
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号